Catalyst Wire Dossier Catalyst Wire Dossier

SIGNIFOR LAR

PASIREOTIDE · Recordati Rare Diseases, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for SIGNIFOR LAR, covering 2013-07-30 to 2024-07-11. Get the full timeline:

Most recent: FDA Approved: SIGNIFOR LAR — Supplemental Application (Recordati Rare Diseases, Inc.)

See pricing